$Intensity Therapeutics(INTS.US)$Intensity Therapeutics Announced A Business Update Reflecting Progress In Its Phase 3 Sarcoma Clinical Program; FDA Provided "Study May Proceed Letter" For Phase 3 Within 30 Day Period Following IND Submission Benzinga· 3 mins ago
$Tharimmune(THAR.US)$on MEGA WATCH 📢 🎅 🔥 biotech company focused on interventions for inflammatory and oncologic diseases 🔥 Strong technical setup: 4-hour chart demonstrating bullish descending wedge 🔥 Strong pipeline with recently published positive Phase 1 data for TH104, its lead candidate for chronic pruritus in PBC 🔥 Market cap $1m, highly undervalued, should easily be a minimum $6m market cap 🔥Oversold, RSI 25 🔥 Recently closed offering (priced at $1.00/sh),...
+4
4
1
举报
Double_Bottom :
looks like public offering of 10 millions shares diluted the stock price. despite the current good news stock price remain downward trend.
Big Bully 81楼主 :
I'm long as well, averaged down and bought the dip. but ya man that drop was brutal, hopefully up from here, 3700 at 6.75 average, let's go!! GL
Talamo's experience is expected to help the company transition as they aim to treat solid tumors with INT230-6. His joining is crucial as the lead drug, INT230-6, is set to enter a Phase 3 trial.
$Intensity Therapeutics(INTS.US)$ potentially groundbreaking anti-cancer therapy without the conventional oncologic therapeutic side effects. As a health care provider, I will tell you: this is huge!
3
1
举报
Jaguar8 :
Indeed. An RCT trial result is compelling.
Intensity Therapeutics股票讨论区
Ph2 readouts in Q1 2024...
$Leap Therapeutics(LPTX.US)$ Phase 2
$Vera Therapeutics(VERA.US)$ Phase 2b
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$Akero Therapeutics(AKRO.US)$ Phase 2b
$Spruce Biosciences(SPRB.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$阿里拉姆制药(ALNY.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Annexon(ANNX.US)$ Phase 2a
$Roivant Sciences(ROIV.US)$...
Update
Benzinga· 3 mins ago
THAR on MEGA WATCH 📢 🎅 🎄
🔥 biotech company focused on interventions for inflammatory and oncologic diseases
🔥 Strong technical setup: 4-hour chart demonstrating bullish descending wedge
🔥 Strong pipeline with recently published positive Phase 1 data for TH104, its lead candidate for chronic pruritus in PBC
🔥 Market cap $1m, highly undervalued, should easily be a minimum $6m market cap
🔥Oversold, RSI 25
🔥 Recently closed offering (priced at $1.00/sh),...
Yooo
hooo
Watchlist for Monday, December 11 🎅 🎄 📢 :
Crossing fingers for a good holiday rally 🎅 ☃️
$Intensity Therapeutics(INTS.US)$
$African Agriculture(AAGR.US)$
$Cyngn(CYN.US)$
$PaxMedica(PXMD.US)$
$优品车(UCAR.US)$
$WiSA Technologies(WISA.US)$
$SPDR 标普500指数ETF(SPY.US)$
...
Groundbreaking Intervention
As a health care provider, I will tell you: this is huge!
暂无评论